Results 321 to 330 of about 477,806 (337)
Some of the next articles are maybe not open access.
European Journal of Endocrinology, 2023
The cases of 3 patients with Cushing's disease who developed long-term adrenal insufficiency after discontinuation of prolonged osilodrostat therapy where recently described for the first time.
A. Ferriere +4 more
semanticscholar +1 more source
The cases of 3 patients with Cushing's disease who developed long-term adrenal insufficiency after discontinuation of prolonged osilodrostat therapy where recently described for the first time.
A. Ferriere +4 more
semanticscholar +1 more source
Glucocorticoid induced adrenal insufficiency
British medical journal, 2021Synthetic glucocorticoids are widely used for their anti-inflammatory and immunosuppressive actions. A possible unwanted effect of glucocorticoid treatment is suppression of the hypothalamic-pituitary-adrenal axis, which can lead to adrenal insufficiency.
A. Prete, I. Bancos
semanticscholar +1 more source
Clinical Endocrinology, 2021
Antisecretory data shows a highly effective and prolonged blockade of cortisol secretion with osilodrostat. The drawback is the occurrence of adrenal insufficiency (AI) in roughly a quarter of treated patients.
F. Castinetti, V. Amodru, T. Brue
semanticscholar +1 more source
Antisecretory data shows a highly effective and prolonged blockade of cortisol secretion with osilodrostat. The drawback is the occurrence of adrenal insufficiency (AI) in roughly a quarter of treated patients.
F. Castinetti, V. Amodru, T. Brue
semanticscholar +1 more source
Etomidate, Adrenal Insufficiency and Mortality Associated With Severity of Illness: A Meta-Analysis
Journal of Intensive Care Medicine, 2020Purpose: Etomidate causes adrenal insufficiency. Yet in critically ill patients, it is controversial whether it increases mortality rates above that of comparator anesthetic induction agents. We postulated that etomidate would increase relative mortality
S. Albert, S. Sitaula
semanticscholar +1 more source